Henry Schein, Inc. (NASDAQ: HSIC) is a Healthcare company in the Medical - Distribution industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | S&P 500 | P/E | 24.73 | EPS (ttm) | 3.43 | Insider Own | 5.53% | Shs Outstand | 113.92M | Perf Week | -3.98% |
| Market Cap | 9.66B | Forward P/E | 14.11 | EPS next Y | 6.01 | Insider Trans | 0.16% | Shs Float | 91.85M | Perf Month | -4.98% |
| Enterprise Value | 13.24B | PEG | 2.74 | EPS next Q | 1.34 | Inst Own | - | Short Float | 8.86% | Perf Quarter | 6.16% |
| Income | 403.00M | P/S | 0.71 | EPS this Y | 56.98% | Inst Trans | - | Short Ratio | 6.33 | Perf Half Y | 16.73% |
| Sales | 13.60B | P/B | 2.05 | EPS next Y | 11.63% | ROA | 3.54% | Short Interest | 8.14M | Perf YTD | 12.25% |
| Book/sh | 41.46 | P/C | 61.56 | EPS next 5Y | 9.01% | ROE | 12.37% | 52W High | 92.18 -7.96% | Perf Year | 25.93% |
| Cash/sh | 1.38 | P/FCF | 18.67 | EPS past 3/5Y | -5.78% 3.15% | ROIC | 6.47% | 52W Low | 61.95 36.95% | Perf 3Y | 15.89% |
| Dividend Est. | - | EV/EBITDA | 12.85 | Sales past 3/5Y | 1.40% 5.43% | Gross Margin | 30.31% | Volatility | 2.18% 1.84% | Perf 5Y | 10.53% |
| Dividend TTM | - | EV/Sales | 0.97 | EPS Y/Y TTM | 12.46% | Oper. Margin | 5.69% | ATR (14) | 1.79 | Perf 10Y | 31.82% |
| Dividend Ex-Date | - | Quick Ratio | 0.73 | Sales Y/Y TTM | 7.33% | Profit Margin | 2.96% | RSI (14) | 35.60 | Recom | 2.59 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.32 | EPS Q/Q | 15.45% | SMA20 | -4.29% | Beta | 0.83 | Target Price | 92.33 |
| Payout | 0.00% | Debt/Eq | 0.77 | Sales Q/Q | 6.73% | SMA50 | -3.44% | Rel Volume | 1.80 | Prev Close | 85.04 |
| Employees | 25,000 | LT Debt/Eq | 0.59 | Earnings | Nov 03 | SMA200 | 6.43% | Avg Volume | 1.23M | Price | 84.84 |
| IPO Date | Nov 03, 1995 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 2.46% 2.49% | Net Debt/EBITDA | 3.55 | Volume | 2,202,816 | Change | -0.24% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-19-26 | Reiterated | BTIG | Buy | $100 → $110 |
| Aug-06-26 | Reiterated | Barclays | Overweight | $86 → $100 |
| Aug-05-26 | Reiterated | Barrington | Outperform | $97 → $104 |
| Aug-05-26 | Reiterated | Stifel Nicolaus | Hold | $84 → $95 |
| Aug-05-26 | Reiterated | UBS | Neutral | $89 → $94 |
| Jul-28-26 | Reiterated | UBS | Neutral | $85 → $89 |
| Jul-08-26 | Initiated | BMO Capital | Market Perform | $85 |
| Jun-11-26 | Upgrade | BTIG | Neutral → Buy | $100 |
| May-06-26 | Reiterated | Robert W. Baird | $104 → $97 | |
| May-06-26 | Reiterated | UBS | Neutral | $85 |
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/27/2025 | FY 2024 12/28/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 13,602 | 13,184 | 12,673 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 9,479 | 9,342 | 8,908 | — | — | — | — | — | — | |
| Gross Profit | 4,123 | 3,842 | 3,765 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 3,200 | 3,084 | 3,036 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 149 | 0 | 0 | — | — | — | — | — | — | |
| Operating Income | 774 | 758 | 729 | — | — | — | — | — | — | |
| Interest Expense | 159 | 150 | 131 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -57 | -63 | -72 | — | — | — | — | — | — | |
| Net Income Before Taxes | 558 | 545 | 526 | — | — | — | — | — | — | |
| Income Taxes | 132 | 126 | 128 | — | — | — | — | — | — | |
| Consolidated Net Income | 403 | 398 | 390 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 426 | 419 | 398 | — | — | — | — | — | — | |
| Net Income | 403 | 398 | 390 | — | — | — | — | — | — | |
| EPS (Recurring) | 3.46 | 3.29 | 3.07 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 3.46 | 3.29 | 3.07 | — | — | — | — | — | — | |
| EPS (Diluted) | 3.43 | 3.27 | 3.05 | — | — | — | — | — | — | |
| EBITDA | 1,031 | 1,006 | 941 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 24.73 | 23.28 | 23.09 | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.70 | 0.70 | 0.71 | — | — | — | — | — | — | |
| Gross Margin | 30.31 | 29.14 | 29.71 | — | — | — | — | — | — | |
| Operating Margin | 5.69 | 5.75 | 5.75 | — | — | — | — | — | — | |
| Net Margin | 2.96 | 3.02 | 3.08 | — | — | — | — | — | — | |
| Shares Outstanding | 113 | 121 | 127 | — | — | — | — | — | — | |
| Market Capitalization | 9,587 | 9,212 | 8,943 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| DANIEL WILLIAM K | Director | May 11 '26 | Buy | 69.19 | 10,000 | 691,900 | 20,000 | May 12 |
| Popeck Thomas C | CEO, Henry Schein Products | Mar 19 '26 | Sale | 72.79 | 1,355 | 98,630 | 86,182 | Mar 20 |
| KUEHN KURT P | Director | Mar 10 '26 | Sale | 78.96 | 2,844 | 224,565 | 15,420 | Mar 11 |
| LASKAWY PHILIP A | Director | Mar 05 '26 | Sale | 80.36 | 2,844 | 228,544 | 21,961 | Mar 06 |
| MLOTEK MARK E | EVP, Chief Strategic Officer | Mar 04 '26 | Sale | 80.80 | 5,925 | 478,740 | 80,554 | Mar 06 |
| BERGMAN STANLEY M | Chairman, CEO | Mar 02 '26 | Sale | 81.31 | 43,812 | 3,562,354 | 383,803 | Mar 03 |
| BERGMAN STANLEY M | Chairman, CEO | Feb 27 '26 | Sale | 81.20 | 10,785 | 875,742 | 309,092 | Feb 27 |
| BERGMAN STANLEY M | Chairman, CEO | Feb 26 '26 | Sale | 81.01 | 38,346 | 3,106,591 | 427,615 | Feb 27 |
| DANIEL WILLIAM K | Director | Aug 07 '25 | Buy | 67.08 | 10,000 | 670,800 | 10,000 | Aug 11 |
| LASKAWY PHILIP A | Director | Mar 19 '25 | Sale | 71.04 | 2,604 | 184,999 | 24,805 | Mar 20 |
| Connett Bradford C | CEO, NA Distribution Group | Mar 19 '25 | Sale | 71.15 | 4,036 | 287,161 | 62,688 | Mar 20 |
| KUEHN KURT P | Director | Mar 05 '25 | Sale | 71.55 | 2,787 | 199,396 | 15,687 | Mar 06 |
| Ettinger Michael S | EVP & Chief Operating Officer | Nov 18 '24 | Sale | 75.00 | 12,240 | 918,000 | 87,706 | Nov 20 |
| McGlynn Lorelei | SVP, Chief Human Res. Officer | Sep 06 '24 | Sale | 69.30 | 21,035 | 1,457,726 | 71,833 | Sep 09 |
| MLOTEK MARK E | EVP, Chief Strategic Officer | Aug 14 '24 | Sale | 69.12 | 3,000 | 207,360 | 87,851 | Aug 15 |